NSF Phase II Solid-State Battery Grant Awarded to Piersica NSF Phase II solid-state battery grant — We are thrilled to congratulate our client, Piersica, Inc., on securing a $1 million Phase II grant from the National Science Foundation (NSF). This…
Key Highlights from the Harvard Non-Dilutive Funding Workshop Harvard non-dilutive funding workshop — This week, our CEO Alfredo Sánchez delivered an insightful session at the Harvard Innovation Lab focused on Grants and Other Non-Dilutive Funding. The event was a highlight…
Personalized Medicine Research: How Sanguine Biosciences and Inspiralia Drive Innovation Personalized medicine research is reshaping the future of healthcare. At Inspiralia, we’re proud to have supported Sanguine Biosciences Inc., a former client, in their mission to revolutionize medical research through…
Virtual Reality Surgical Training: Osso VR’s Growth with Inspiralia Virtual reality surgical training is reshaping how medical professionals develop critical skills. At Inspiralia, we take pride in working with innovative companies like Osso VR, a former client revolutionizing surgical training…
Cardiovascular monitoring technology plays a crucial role in modern healthcare. At Inspiralia, we’re proud to support InteloMed Inc. and their cutting-edge solution, CVInsight®. This non-invasive monitoring system delivers real-time cardiovascular insights, empowering clinicians to make faster, more informed decisions that…
Autism Therapy Technology: iTherapy’s Breakthrough with Inspiralia Autism therapy technology is evolving, and at Inspiralia, we’re proud to contribute to innovations that improve lives. One remarkable success story is our partnership with iTherapy LLC, a company redefining autism support through…